Pericarditis / Pericardial Effusion in Horses

Quick Facts

🏥 Condition Name
Pericarditis / Pericardial Effusion
📋 Also Known As
Pericarditis / Pericardial Effusion
📂 Category
Cardiovascular System
📁 Subcategory
N/A
🐴 Affects
Pericardium (sac surrounding the heart) and cardiac function
🏷️ Type
Inflammatory
⚠️ Severity
Moderate to Life-threatening
💊 Treatable
Yes, with aggressive treatment, though prognosis varies
🔄 Contagious
Underlying infection may be contagious; pericarditis itself is not
🧬 Hereditary
No
🐴 Common In
All horse breeds, often secondary to respiratory or systemic infections

Pericarditis / Pericardial Effusion Overview

Pericarditis is an inflammatory condition of the pericardium, the fibrous sac that surrounds and protects the heart. This condition frequently involves accumulation of fluid within the pericardial space, known as pericardial effusion, which can progressively compromise cardiac function as the fluid volume increases. The pericardium normally contains only a small amount of lubricating fluid that allows the heart to beat without friction against surrounding structures. When inflammation causes excessive fluid production or prevents normal fluid resorption, the resulting effusion can significantly impair the heart's ability to fill and pump effectively.

Pericarditis represents an uncommon but potentially devastating condition in horses, with reported cases spanning all ages, breeds, and uses. The condition most frequently develops as a complication of bacterial infection, often originating from respiratory disease or penetrating wounds. Viral, parasitic, and neoplastic causes also occur but less frequently. Because the early signs can be nonspecific and easily attributed to other conditions, pericarditis may be underdiagnosed or diagnosed late in its course when significant effusion has already accumulated. The consequences of delayed recognition and treatment can be severe.

The impact of pericarditis on equine health depends largely on the volume of pericardial fluid that accumulates and the speed at which it develops. Small, slowly developing effusions may produce minimal clinical signs as the pericardium stretches to accommodate the extra fluid. Larger or rapidly developing effusions cause cardiac tamponade, a life-threatening condition in which external pressure prevents the heart from filling adequately. Without intervention, tamponade leads to cardiovascular collapse and death. Even with successful treatment, some horses develop constrictive pericarditis, a chronic condition in which the damaged pericardium restricts cardiac motion permanently.

With aggressive treatment including appropriate antimicrobial therapy and drainage of pericardial effusion when necessary, some horses with pericarditis can recover completely. However, the overall prognosis for this condition is guarded, particularly in cases of septic pericarditis, which carries a mortality rate estimated at 50 percent or higher despite intensive treatment. Early recognition of this condition and prompt institution of appropriate therapy offer the best opportunity for successful outcomes. Understanding the potential for pericarditis to complicate respiratory and other infections helps veterinarians and owners recognize when cardiac evaluation is warranted.

Causes of Pericarditis / Pericardial Effusion

The primary causes of pericarditis in horses typically involve infectious agents reaching the pericardial space. Bacterial infection represents the most common etiology, frequently arising from extension of pleuropneumonia or other respiratory infections. The bacteria may spread to the pericardium through direct extension from infected pleural fluid, via the bloodstream from a distant focus of infection, or through migrating foreign bodies such as wire or plant material penetrating from the gastrointestinal tract. Common bacterial isolates include Streptococcus species, Actinobacillus equuli, and various gram-negative organisms. Mixed infections involving multiple bacterial species occur frequently, particularly in cases arising from penetrating wounds or foreign body migration.

While pericarditis is not a hereditary condition, certain individual factors may influence susceptibility or disease progression. Horses with compromised immune function may be more vulnerable to the initial infections that can spread to involve the pericardium. Those with anatomical abnormalities affecting thoracic drainage may be predisposed to accumulation of infected material adjacent to the heart. However, any horse can develop pericarditis under appropriate circumstances, and no specific genetic susceptibility has been identified. The condition affects horses of all breeds and ages without apparent predilection.

Environmental and management factors influence pericarditis risk primarily through their effects on respiratory disease incidence and exposure to potential penetrating foreign bodies. Horses housed in poorly ventilated barns face increased respiratory pathogen exposure. Overcrowding promotes disease transmission. Feeding hay or other forage containing wire, hardware, or sharp plant material creates risk for traumatic reticuloperitonitis and potential foreign body migration toward the heart. Pastures containing metallic debris pose similar hazards. Poor biosecurity during disease outbreaks increases exposure to pathogens capable of causing severe respiratory disease that may extend to involve the pericardium.

Risk factors for developing pericarditis include recent or current respiratory infection, particularly severe pneumonia or pleuropneumonia. Horses with compromised immune status from stress, concurrent illness, or immunosuppressive conditions are at elevated risk. Thoracic trauma, including penetrating wounds and fractured ribs, can introduce bacteria directly into the thoracic cavity. Ingestion of foreign bodies capable of migrating through the gastrointestinal wall creates risk for traumatic pericarditis. Certain neoplasms, particularly lymphoma, can involve the pericardium. Previous thoracic surgery creates potential pathways for infection.

The pathophysiology of pericarditis involves inflammation of the pericardial membranes with variable degrees of effusion and potential structural damage. When infectious agents or other inflammatory stimuli reach the pericardium, they trigger an acute inflammatory response characterized by vascular dilation, increased permeability, and infiltration of inflammatory cells. Exudation of protein-rich fluid into the pericardial space follows. In bacterial pericarditis, the effusion often becomes frankly purulent with large numbers of bacteria and neutrophils. The rate of fluid accumulation determines clinical impact; slow accumulation allows compensatory pericardial stretching, while rapid accumulation causes tamponade. Over time, fibrin deposition and organization can lead to adhesions between the pericardial layers. In some cases, the inflammation results in permanent pericardial thickening and restriction, causing constrictive pericarditis that chronically impairs cardiac function.

Symptoms & Warning Signs

Early warning signs of pericarditis may be subtle and easily confused with symptoms of the underlying condition that typically precedes cardiac involvement. Because horses instinctively minimize displays of weakness or illness, early pericardial inflammation often goes unrecognized. Fever may be present, particularly in infectious cases, though it may be attributed to respiratory infection rather than cardiac involvement. Mild depression and decreased appetite commonly occur. Subtle reluctance to move or exercise may be noticed. Changes in heart rate or muffling of heart sounds may be detected during routine physical examination but are easily overlooked without specific focus on the cardiovascular system.

As pericardial effusion develops and increases in volume, more characteristic symptoms emerge. Exercise intolerance becomes pronounced, with the horse showing weakness and reluctance to move even short distances. Peripheral edema develops in dependent areas including the ventral abdomen, sheath or udder, and lower limbs as venous return to the heart becomes compromised. Jugular veins become distended and may show abnormal pulsation as elevated venous pressure prevents normal drainage. The respiratory rate increases as the lungs attempt to compensate for reduced cardiac output. The heart rate elevates in an attempt to maintain circulation despite reduced stroke volume.

Behavioral changes accompany the progression of pericarditis as the horse experiences the effects of cardiovascular compromise. Affected horses typically display marked depression and may appear anxious or distressed. Appetite decreases substantially, and weight loss may occur rapidly. The horse may adopt a characteristic stance with the forelegs abducted and elbows turned outward to maximize thoracic space. Reluctance to lie down is common, as recumbency may worsen respiratory and cardiovascular function. When forced to move, the horse shows obvious weakness and may require frequent rest. Social isolation from herd mates often occurs.

Physical signs detected on veterinary examination provide important diagnostic information. Auscultation of the heart may reveal muffled heart sounds as fluid accumulates between the heart and the stethoscope. Pericardial friction rubs, rough scratching sounds coinciding with cardiac motion, may be heard in early or dry pericarditis before significant effusion develops. The heart rate is typically elevated, often markedly so in advanced cases. Jugular venous distension is a classic finding, with the veins remaining filled even when the horse's head is elevated. Pulse quality may be weak with reduced amplitude during inspiration, known as pulsus paradoxus. Mucous membranes may appear pale or congested.

The progression of symptoms in pericarditis often follows an accelerating course as effusion volume increases. Initially mild signs may persist for days to weeks depending on the rate of fluid accumulation. However, as the pericardial space fills and the limits of compensatory stretching are reached, clinical deterioration can become rapid. Signs of cardiac tamponade develop when pericardial pressure prevents adequate cardiac filling, including severe tachycardia, marked jugular distension, profound weakness, and cardiovascular collapse. Without emergency intervention, tamponade is rapidly fatal.

Emergency symptoms requiring immediate veterinary attention include severe weakness or collapse indicating cardiovascular failure. Marked respiratory distress with rapid, labored breathing suggests advanced cardiac compromise or concurrent pulmonary involvement. Profound distension of the jugular veins with visible abnormal pulsation indicates severely elevated venous pressure. Extremely rapid heart rate exceeding 80 to 100 beats per minute signals critical cardiovascular compromise. Cold extremities despite warm environmental temperatures indicate peripheral circulatory failure. Any sudden deterioration in a horse with suspected or confirmed pericarditis constitutes an emergency requiring immediate intervention. Delay in treatment during acute tamponade can result in death within hours.

Diagnosis

The diagnostic process for pericarditis begins with thorough physical examination by a licensed equine veterinarian with particular attention to the cardiovascular system. Cardiac auscultation assesses for muffled heart sounds, which occur when fluid separates the heart from the chest wall, or pericardial friction rubs in early dry pericarditis. Heart rate and rhythm are evaluated. Examination of the jugular veins for distension and abnormal pulsation provides important information about venous pressure. Assessment of pulse quality, mucous membrane color, and capillary refill time indicates circulatory status. The history, including any recent respiratory infection, fever, exposure to potential foreign bodies, or thoracic trauma, provides crucial context for diagnostic interpretation.

Diagnostic testing confirms the diagnosis and characterizes the extent and nature of pericardial involvement. Echocardiography represents the definitive diagnostic tool, providing direct visualization of pericardial fluid surrounding the heart. The volume of effusion, characteristics of the fluid, presence of fibrin strands or loculations, and any thickening of the pericardium can be assessed. Cardiac function and chamber dimensions are evaluated to determine hemodynamic impact. Electrocardiography may reveal reduced voltage of electrical complexes due to the insulating effect of pericardial fluid. Blood work including complete blood count and fibrinogen levels reflects the degree of systemic inflammation.

Advanced diagnostic procedures provide additional information for treatment planning and prognostication. Pericardiocentesis, the aspiration of fluid from the pericardial space, serves both diagnostic and therapeutic purposes. Analysis of the pericardial fluid including cytology, protein content, and bacterial culture helps identify the underlying cause and guide antimicrobial selection. Thoracic radiography may reveal cardiac silhouette enlargement consistent with effusion and may identify concurrent lung pathology. Thoracic ultrasound beyond echocardiography can evaluate for pleural effusion or other thoracic abnormalities. Blood cultures may identify organisms in cases of septicemia.

Differential diagnosis for pericarditis includes other causes of the clinical signs of cardiac dysfunction and thoracic disease. Congestive heart failure from primary cardiac disease produces similar signs of exercise intolerance and peripheral edema but without the characteristic muffled heart sounds or echocardiographic appearance of pericardial effusion. Pleuropneumonia causes respiratory distress and may coexist with or be mistaken for pericarditis. Mediastinal masses or abscesses can cause similar jugular distension and cardiac compression. Myocarditis may accompany pericarditis or occur independently. Neoplasia involving the heart or pericardium can produce effusion. Thorough diagnostic workup including echocardiography distinguishes these conditions and identifies concurrent problems.

Treatment Options

Immediate treatment of pericarditis focuses on relieving cardiac tamponade when present and addressing the underlying cause. When significant pericardial effusion is causing cardiovascular compromise, pericardiocentesis provides life-saving drainage of the accumulated fluid. This procedure involves insertion of a needle or catheter through the chest wall into the pericardial space under echocardiographic guidance to drain the effusion. The immediate improvement in cardiac function following drainage can be dramatic, with heart rate decreasing and blood pressure improving as the heart is freed from external compression. In some cases, a drainage catheter may be left in place to allow continued drainage or repeated aspiration.

Medical management forms the foundation of pericarditis treatment regardless of whether drainage is required. Aggressive antimicrobial therapy is essential in bacterial pericarditis, with drug selection ideally based on culture and sensitivity results from pericardial fluid. Pending culture results, broad-spectrum antibiotics effective against common causative organisms should be initiated immediately. Treatment duration typically extends for several weeks to ensure complete eradication of infection. Anti-inflammatory therapy using nonsteroidal anti-inflammatory drugs helps control inflammation and provides comfort. Diuretics may be indicated to manage peripheral edema, though their use must be balanced against the need to maintain circulating volume.

Surgical intervention may be necessary in cases that do not respond adequately to medical management and pericardiocentesis. Surgical approaches to pericardial drainage provide more complete removal of thick, purulent material that cannot be aspirated through a needle. Creation of a pericardial window allows continuous drainage into the thoracic or abdominal cavity. Pericardiectomy, surgical removal of part or all of the pericardium, may be considered in cases of constrictive pericarditis or recurrent effusion. These surgical procedures carry significant risk and are typically reserved for cases failing more conservative management. Referral to a surgical center with appropriate facilities and experience may be recommended.

Supportive care measures are essential throughout the treatment of pericarditis. Intravenous fluid therapy supports circulation but must be administered cautiously to avoid volume overload in a heart with compromised filling. Nutritional support maintains body condition during what may be a prolonged illness. Pain management improves comfort and reduces stress. Rest is essential to minimize cardiac demands during recovery. Close monitoring allows early detection of recurrent effusion or other complications. Oxygen supplementation may benefit horses with compromised oxygenation.

Rehabilitation following recovery from pericarditis requires extended rest and gradual return to activity. The pericardium and any associated myocardial involvement require time to heal completely. Premature return to exercise risks recurrence or cardiac complications. The duration of rest depends on the severity of the initial disease and response to treatment, typically ranging from several weeks to months. Serial echocardiographic examination monitors for recurrent effusion or development of constrictive changes. Return to work should be gradual with careful monitoring for exercise intolerance.

Treatment decisions in pericarditis are influenced by disease severity, response to initial therapy, and financial considerations. Mild cases detected early may respond to medical therapy alone. More severe cases require intensive treatment including pericardiocentesis and prolonged antimicrobial therapy. Surgical intervention adds cost and risk but may be necessary for refractory cases. The overall guarded prognosis, particularly for septic pericarditis, should be discussed frankly with owners. Quality of life assessment should guide decisions about continuing or intensifying treatment. Euthanasia may be appropriate for horses that fail to respond to aggressive therapy, develop intractable complications, or have severely compromised quality of life.

Recovery & Prognosis

The recovery timeline for pericarditis varies substantially depending on the underlying cause, severity of disease, and response to treatment. Horses with mild, non-septic pericarditis may show improvement within days to weeks with appropriate treatment. Septic pericarditis typically requires weeks to months of treatment before resolution, and some cases never fully resolve. Complete resolution of pericardial effusion may take several weeks even after clinical improvement is apparent. Development of constrictive pericarditis, when the pericardium becomes permanently thickened and restrictive, represents failure of complete recovery and constitutes a chronic condition with its own management challenges.

Post-treatment care and monitoring are essential components of recovery from pericarditis. Serial echocardiographic examination tracks resolution of pericardial fluid and identifies recurrence or development of constrictive changes. The frequency of follow-up depends on disease severity and response to treatment, with initial rechecks often occurring every one to two weeks. Electrocardiographic monitoring evaluates for arrhythmias that may complicate recovery. Blood work including white blood cell count and fibrinogen levels tracks resolution of systemic inflammation. Antimicrobial therapy typically continues for weeks beyond clinical improvement to ensure complete eradication of infection when bacterial causes are involved.

Prognosis for horses with pericarditis depends on multiple factors. The underlying cause significantly influences outcome; idiopathic or viral pericarditis generally carries a better prognosis than septic pericarditis. Overall mortality rates for septic pericarditis are estimated at 50 percent or higher despite aggressive treatment. Horses that respond well to initial treatment and show resolution of effusion on follow-up examination have improved prospects. Development of cardiac tamponade requiring emergency drainage indicates more severe disease. Progression to constrictive pericarditis limits long-term function even if the horse survives the acute episode. Early detection and prompt aggressive treatment offer the best opportunity for favorable outcome.

Long-term outlook for horses recovering from pericarditis requires realistic assessment based on the individual case. Horses with complete resolution may eventually return to previous function, though extended rest and gradual rehabilitation are necessary. Those that develop constrictive pericarditis face chronic limitations with reduced exercise tolerance and potential for progressive heart failure. Performance careers may not be possible for horses with significant residual cardiac effects. Regular monitoring throughout life helps detect late deterioration or complications. Quality of life for horses with residual effects depends on the degree of cardiac compromise and the horse's expected use. With appropriate management, even horses with permanent effects can sometimes maintain comfortable retirement.

Prevention

Prevention of pericarditis focuses on management practices that reduce respiratory disease incidence and exposure to potential causes of traumatic pericarditis. Biosecurity measures limit introduction and spread of respiratory pathogens that can progress to involve the pericardium. Quarantine of new arrivals, isolation of sick horses, and hygiene protocols for personnel and equipment reduce disease transmission. Adequate ventilation in barns decreases respiratory pathogen concentration and reduces disease severity. Avoiding overcrowding minimizes stress and disease exposure. Prompt treatment of respiratory infections before they can progress to involve thoracic structures reduces the risk of secondary pericarditis.

Nutritional considerations for preventing pericarditis relate primarily to forage quality and feeding management. Hay and other forages should be carefully inspected for wire, hardware, and other foreign material that could cause traumatic injury if ingested. Feeding areas should be maintained free of debris that horses might accidentally consume. Magnets placed in feed processing equipment can remove metallic contamination. Balanced nutrition supports immune function and the ability to resist and recover from infections. Adequate vitamin E and selenium support cardiac muscle health and immune function.

Exercise and conditioning guidelines for preventing pericarditis emphasize the importance of rest during respiratory illness. Horses with fever or respiratory symptoms should not be exercised until complete recovery, as continued physical demands stress an already compromised system and may promote spread of infection to additional tissues. Gradual return to training following illness allows monitoring for signs of cardiac involvement. Appropriate conditioning programs support overall fitness and disease resistance.

Environmental factors affecting pericarditis prevention include pasture maintenance to remove metallic debris and hazardous objects that could be ingested. Barn construction and maintenance should prevent horses from accessing wire, nails, or other hardware. Regular inspection of fencing for broken wires reduces exposure to potential foreign bodies. Air quality management through proper ventilation, dust control, and ammonia reduction supports respiratory health and reduces the risk of severe respiratory infections that could extend to involve the pericardium.

Vaccination contributes to prevention by reducing the incidence and severity of respiratory infections that can precede pericarditis. Core vaccines should be maintained on appropriate schedules. Influenza vaccination is particularly important given the frequency of respiratory disease as a precursor to thoracic infections. Strangles vaccination may be appropriate in endemic areas or high-risk situations. Other vaccines may be indicated based on regional disease risks. While vaccination cannot eliminate respiratory disease, it reduces severity and the likelihood of serious complications. Regular deworming prevents parasitic migration that could theoretically cause pericardial involvement.

Living With & Managing Pericarditis / Pericardial Effusion

Daily management adjustments for horses recovering from or living with sequelae of pericarditis depend on the extent of recovery and any residual cardiac effects. During the acute treatment phase, horses require intensive care with close monitoring and minimal stress. Once stabilized, management focuses on supporting recovery while minimizing cardiac demands. Feeding schedules should provide frequent small meals to reduce metabolic stress. Elevated feed and water positions may improve comfort if respiratory effort is increased. Calm, predictable handling routines minimize excitement and cardiovascular stress. Observation for signs of recurrent effusion, including changes in respiratory rate, heart rate, or edema, should occur multiple times daily.

Housing and turnout considerations for horses with pericarditis history depend on disease stage and residual effects. Complete stall rest is typically indicated during active treatment and early recovery. The stall should be comfortable with adequate bedding and protection from temperature extremes. Once the acute phase resolves and echocardiographic follow-up confirms resolution of effusion, gradual introduction to small paddock turnout allows gentle self-exercise. Turnout companions should be calm individuals unlikely to encourage strenuous activity. Larger pastures with multiple active horses are generally inappropriate until cardiac function is confirmed stable. Continued housing modifications may be necessary for horses with permanent cardiac effects.

Exercise modifications following pericarditis require careful veterinary guidance based on ongoing cardiac evaluation. No exercise should occur during active disease or until follow-up examinations confirm resolution of effusion and adequate cardiac function. The duration of mandatory rest depends on disease severity and may extend for months following severe septic pericarditis. Return to work begins with hand-walking and progresses very gradually based on cardiac evaluation and absence of exercise intolerance. Horses that develop constrictive pericarditis face permanent exercise limitations, with the degree of restriction depending on the severity of cardiac compromise.

Monitoring and ongoing care requirements for horses with pericarditis history include regular veterinary evaluation and owner vigilance for signs of recurrence or complications. Periodic echocardiographic examination monitors for recurrent effusion or development of constrictive changes. The frequency of follow-up depends on the severity of initial disease and presence of any residual effects. Owners should monitor resting respiratory rate and character, heart rate when possible, and watch for peripheral edema. Any recurrence of signs suggesting cardiac compromise warrants immediate veterinary evaluation. Horses on continued antimicrobial therapy require appropriate monitoring for adverse effects.

Quality of life and use considerations for horses affected by pericarditis range widely depending on outcome. Horses with complete resolution may eventually return to previous activities following appropriate rehabilitation. Those with mild residual effects may be suitable for light work or retirement as companions. Horses with significant constrictive pericarditis may face substantially diminished quality of life with chronic exercise intolerance and progressive heart failure. Quality of life assessment should consider comfort, ability to perform normal behaviors, and the horse's apparent well-being. Humane euthanasia becomes appropriate when quality of life deteriorates significantly or when suffering cannot be adequately controlled.

Breeds at Risk for Pericarditis / Pericardial Effusion

Pericarditis does not demonstrate breed predisposition because it typically results from infectious or traumatic causes rather than inherited susceptibility. All breeds of horses are equally vulnerable to the infections and injuries that can lead to pericardial involvement. Neither conformation differences nor genetic factors have been identified as increasing risk for this condition. The sporadic nature of pericarditis cases reflects the opportunistic development of disease from varied inciting causes rather than any breed-related vulnerability. Any horse with appropriate exposure to causative factors can develop pericarditis.

Breed-related management patterns may indirectly influence pericarditis risk through effects on exposure to potential causes. Horses housed in intensive management situations with frequent commingling, such as racing and competition operations, face increased respiratory disease exposure. This may translate to slightly higher risk for respiratory-origin pericarditis in Thoroughbreds, Standardbreds, and sport horses, though this reflects management rather than breed susceptibility. Horses at pasture with access to areas containing metallic debris may face increased traumatic pericarditis risk regardless of breed. Draft horses and other breeds used in agricultural settings might have different exposure patterns to potential foreign bodies.

Genetic testing has no role in predicting pericarditis risk because the condition is not hereditary. Breeding decisions are not affected by pericarditis history, as the condition does not transmit to offspring. General recommendations for all breeds focus on preventive measures including appropriate vaccination, biosecurity, and environmental safety. Recognition that pericarditis can affect any breed emphasizes the importance of universal vigilance for this condition, particularly following respiratory illness. Early detection and aggressive treatment improve outcomes regardless of breed, making awareness of clinical signs important for all horse owners.

Related Conditions

Several conditions commonly co-occur with or precede the development of pericarditis. Pleuropneumonia represents the most common precursor, with bacterial infection spreading from the lungs and pleural space to involve the pericardium. The combination of pleural and pericardial involvement significantly worsens prognosis. Myocarditis may accompany pericarditis when infectious agents affect both the pericardial sac and the underlying heart muscle. Endocarditis affecting the heart valves can occur in the context of bacteremia that also causes pericarditis. Recognition of these related conditions is important for comprehensive treatment planning, as addressing only one component of multi-structure cardiac involvement leads to treatment failure.

Conditions presenting with similar clinical signs to pericarditis require differentiation for appropriate treatment. Congestive heart failure from valvular disease or cardiomyopathy causes exercise intolerance and peripheral edema but without pericardial effusion on echocardiography. Pleuropneumonia causes respiratory distress and may coexist with pericarditis; thorough thoracic evaluation identifies all involved structures. Mediastinal masses can cause jugular distension and cardiac compression without primary pericardial inflammation. Severe anemia causes weakness and tachycardia but with different examination findings. Comprehensive diagnostic workup including echocardiography distinguishes pericarditis from conditions with overlapping presentations.

Potential complications of pericarditis extend the clinical impact and influence prognosis. Cardiac tamponade from rapidly accumulating or large-volume effusion represents a life-threatening emergency. Constrictive pericarditis develops when healing involves excessive fibrosis that permanently restricts cardiac motion, causing chronic exercise intolerance and potential heart failure. Septicemia may develop from pericardial infection seeding the bloodstream. Extension of infection to involve the myocardium or endocardium worsens cardiac dysfunction. Adhesions between the pericardium and epicardium may persist following resolution of effusion. Recognition of these potential complications guides monitoring and treatment decisions throughout the course of disease.